Search Results

Displaying Results 1401-1425 of 19325 "'SAN'"

Mar 17, 2026, 23:30 ET Innodisk at NVIDIA GTC 2026: Accelerating Real-World AI for Healthcare and Mobility with Full-Stack Edge Solutions

SAN JOSE, Calif., March 18, 2026 /PRNewswire/ -- Innodisk, a leading global AI solution provider, today announced its participation in NVIDIA GTC 2026. Alongside subsidiary Aetina, Innodisk Group is showcasing the seamless

More news about: Innodisk Corporation


Mar 17, 2026, 20:30 ET Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs

the 2026 American Association for Cancer Research Annual Meeting (AACR 2026), taking place from April 17th to 22th, at the San Diego Convention Center, California, the United States. The presentations will feature ATG-125 (B7-H3 x PD-L1 bispecific antibody-drug conjugate [ADC]),

More news about: Antengene Corporation Limited


Mar 17, 2026, 20:01 ET Nscale y Microsoft anuncian una colaboración con NVIDIA y Caterpillar para entregar 1,35GW de GPU NVIDIA Vera Rubin NVL72 en el emblemático AI Factory Campus en Virginia Occidental

nivel mundial para la implementación de la arquitectura Vera Rubin de NVIDIA y de NVIDIA DSX AI FactorySAN JOSÉ, California, 17 de marzo de 2026 /PRNewswire/ -- Nscale firmó una carta de intenciones con Microsoft

More news about: Nscale


Mar 17, 2026, 20:00 ET A Nscale e a Microsoft anunciam parceria com a NVIDIA e a Caterpillar para fornecer 1,35 GW de GPUs NVIDIA Vera Rubin NVL72 ao campus da fábrica de IA de ponta na Virgínia Ocidental

principal parceira global de implantação da arquitetura NVIDIA Vera Rubin e da Fábrica de IA DSX NVIDIASAN JOSE, Califórnia, 17 de março de 2026 /PRNewswire/ -- A Nscale assinou uma carta de intenções com a Microsoft

More news about: Nscale


Mar 17, 2026, 19:54 ET Nscale et Microsoft annoncent leur collaboration avec NVIDIA et Caterpillar pour fournir 1,35 GW de GPU NVIDIA Vera Rubin NVL72 sur le campus phare de l'usine d'IA en Virginie-Occidentale.

que partenaire de déploiement mondial pour l'architecture NVIDIA Vera Rubin et NVIDIA DSX AI Factory.SAN JOSE, Californie, 18 mars 2026 /PRNewswire/ -- Nscale a signé une lettre d'intention avec Microsoft pour

More news about: Nscale


Mar 17, 2026, 19:30 ET Vieworks to Debut VISQUE DPS LH210 at USCAP 2026, a Single Scanner for Both Cytology and Histology

2026 (United States & Canadian Academy of Pathology Annual Meeting), held from March 23 to 25 at the Henry B. González Convention Center in San Antonio, Texas. At the exhibition, Vieworks will present its latest digital pathology solutions at booth 352, featuring the VISQUE DPS

More news about: Vieworks Co., Ltd.


Mar 17, 2026, 19:30 ET Vieworks to Debut VISQUE DPS LH210 at USCAP 2026, a Single Scanner for Both Cytology and Histology

2026 (United States & Canadian Academy of Pathology Annual Meeting), held from March 23 to 25 at the Henry B. González Convention Center in San Antonio, Texas. At the exhibition, Vieworks will present its latest digital pathology solutions at booth 352, featuring the VISQUE DPS

More news about: Vieworks Co., Ltd.


Mar 17, 2026, 19:00 ET Verismo Therapeutics to Present Novel Multi-chain KIR-CAR Data - Including Initial Clinical Trial Results for Lead Immuno-Oncology Candidates SynKIR™-110 and SynKIR™-310 - at AACR Annual Meeting 2026

today announced its participation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026, which will be held April 17-22 in San Diego, California. The company will present new clinical, preclinical, and translational KIR-CAR data in three separate presentations, supporting the

More news about: Verismo Therapeutics


Mar 17, 2026, 19:00 ET Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

TAIPEI and SAN DIEGO, March 17, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases,

More news about: Senhwa Biosciences, Inc.


Mar 17, 2026, 18:47 ET Brayton Purcell LLP Responds to San Jose Mercury News Investigation Highlighting Bay Area Silicosis Crisis Tied to Crystalline Silica Artificial Stone

/PRNewswire/ -- Brayton Purcell LLP today responded to major reporting published yesterday by the San Jose Mercury News, which documents the rapidly accelerating epidemic of silicosis among San Francisco Bay Area workers who fabricate crystalline silica artificial stone. The article, written

More news about: Brayton Purcell LLP


Mar 17, 2026, 18:43 ET WEKA, NVIDIA BlueField-4 STX पर प्रति टोकन कम लागत के साथ टोकन आउटपुट को अधिक से अधिक बढ़ाता है

टोकन उत्पादन 6.5 गुना बढ़ गया है, जिससे AI आधारित कंपनियों के लिए इंफरेंस (AI चलाने) की लागत काफी कम हो गई है।SAN JOSE, Calif. और CAMPBELL, Calif., 18 मार्च, 2026 /PRNewswire/ -- जीटीसी 2026 से: 

More news about: WEKA


Mar 17, 2026, 18:40 ET WEKA optimise la production de jetons avec un coût inférieur par jeton sur NVIDIA BlueField-4 STX

même empreinte de GPU, réduisant ainsi le coût de l'inférence pour les organisations fonctionnant avec l'IASAN JOSE, Californie et CAMPBELL, Californie, 17 mars 2026 /PRNewswire/ -- En direct de la conférence GTC 2026 :

More news about: WEKA


Mar 17, 2026, 18:23 ET Aeropres Corporation and Oberon Announce Partnership to Bring AeroNu™ Renewable DME Propellant to the Aerosol Industry

Joint Initiative Creates Commercial Availability of Renewable DME for Aerosol ApplicationsSHREVEPORT, La. and SAN DIEGO, March 17, 2026 /PRNewswire/ -- Aeropres Corporation and Oberon today announced a strategic

More news about: Aeropres Corporation


Mar 17, 2026, 17:29 ET WEKA verkürzt die Bereitstellungszeiten für AI Factories von Monaten auf Minuten - dank einer sofort einsatzbereiten NVIDIA-Lösung für KI-Datenplattformen

und rentabler Produktion und liefert skalierbare Business Intelligence und schnellere KI-Ergebnisse mit NVIDIASAN JOSE und CAMPBELL, Kalifornien, 17. März 2026 /PRNewswire/ -- Von der GTC 2026:

More news about: WEKA


Mar 17, 2026, 17:15 ET Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026

ROS1-selective inhibitor, during two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026, being held April 17-22 in San Diego. The posters will highlight clinical data from a subset of TKI pre-treated patients with ROS1-positive NSCLC treated in the ARROS-1 Phase 1/2 clinical

More news about: Nuvalent, Inc.


Mar 17, 2026, 17:00 ET GV20 Therapeutics Announces Late-Breaking Oral Presentation of GV20-0251 Translational Findings at the AACR Annual Meeting 2026

late-breaking oral presentation highlighting translational data of GV20-0251 at the American Association of Cancer Research 2026 Annual Meeting, taking place in San Diego on April 17- 22, 2026.

More news about: GV20 Therapeutics


Mar 17, 2026, 16:48 ET Juice Labs Joins NVIDIA AI Grid Ecosystem, Delivering the Connectivity Fabric for Distributed Intelligence at the Telco Edge

SAN JOSE, Calif., March 17, 2026 /PRNewswire/ -- Juice Labs today announced at NVIDIA GTC 2026 that its GPU-over-IP platform has joined the

More news about: Juice Labs


Mar 17, 2026, 16:35 ET Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026

that new data will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place April 17–22, 2026, in San Diego, California. These data include updated results from the TRUST-I and TRUST-II clinical studies highlighting the efficacy and safety of IBTROZI® (taletrectinib)

More news about: Nuvation Bio Inc.


Mar 17, 2026, 16:30 ET Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting

trial of first-in-class anti-CD161 antibody, IMT-009, at the American Association for Cancer Research (AACR) Annual Meeting, held April 17-22, 2026 in San Diego, California. Data to be presented support continued development of IMT-009 as a novel cancer immunotherapy for treatment of solid tumors and hematologic

More news about: Immunitas Therapeutics, Inc.


Mar 17, 2026, 16:30 ET Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

antibody-drug conjugate (ADC) portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22, 2026, in San Diego, CA."For the first time, we will present comprehensive preclinical proof-of-concept for our three ADC programs, HWK-007, HWK-016 and HWK-206,"

More news about: Whitehawk Therapeutics, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.